لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Shiota H; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Alekseyenko AA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., Wang ZA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Filic I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Knox TM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Luong NM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Huang Y; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Scott DA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Jones KL; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Lemieux ME; Bioinfo, Plantagenet, Ontario, Canada., Cole PA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Kuroda MI; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts., French CA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. cfrench@bwh.harvard.edu.

المصدر: Molecular cancer research : MCR [Mol Cancer Res] 2021 Nov; Vol. 19 (11), pp. 1818-1830. Date of Electronic Publication: 2021 Jul 20.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell/*drug therapy , Carcinoma, Squamous Cell/*genetics , Cell Cycle Proteins/*genetics , Early Detection of Cancer/*methods , High-Throughput Nucleotide Sequencing/*methods , Histone Deacetylase Inhibitors/*therapeutic use , Nuclear Proteins/*genetics , Transcription Factors/*genetics, Animals ; Cell Line, Tumor ; Female ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; Male ; Mice

المؤلفون: Morrison-Smith CD; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Knox TM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Filic I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Soroko KM; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Eschle BK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Wilkens MK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Giles F; Developmental Therapeutics Consortium, Chicago, Ilinois., Griffin A; Praxis Precision Medicines, Cambridge, Massachusetts., Brown B; Paraza Pharma Inc., Montreal, Quebec, Canada., Shapiro GI; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zucconi BE; Department of Medicine, Division of Genetics, Brigham and Women's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Cole PA; Department of Medicine, Division of Genetics, Brigham and Women's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts., Lemieux ME; Bioinfo, Plantagenet, Ontario, Canada., French CA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. cfrench@bwh.harvard.edu.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Jul; Vol. 19 (7), pp. 1406-1414. Date of Electronic Publication: 2020 May 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Benzimidazoles/*pharmacology , Carcinoma/*drug therapy , Cell Cycle Proteins/*antagonists & inhibitors , E1A-Associated p300 Protein/*antagonists & inhibitors , Gene Expression Regulation, Neoplastic/*drug effects , Neoplasm Proteins/*antagonists & inhibitors , Nuclear Proteins/*antagonists & inhibitors , Pyridones/*pharmacology , Transcription Factors/*antagonists & inhibitors, Animals ; Apoptosis ; Biomarkers, Tumor ; Carcinoma/metabolism ; Carcinoma/pathology ; Cell Cycle ; Cell Proliferation ; Humans ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays

المؤلفون: Ferris CF; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States.; Depts Psychology and Pharmaceutical Sciences, Northeastern University, United States., Nodine S; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Pottala T; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Cai X; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Knox TM; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Fofana FH; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Kim S; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Kulkarni P; Center for Translational NeuroImaging, Northeastern University, Boston, MA, United States., Crystal JD; Dept of Psychology and Brain Sciences, Indiana University, Bloomington, IN, United States., Hohmann AG; Dept of Psychology and Brain Sciences, Indiana University, Bloomington, IN, United States.

المصدر: Neurobiology of pain (Cambridge, Mass.) [Neurobiol Pain] 2019 May 27; Vol. 6, pp. 100034. Date of Electronic Publication: 2019 May 27 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 101705141 Publication Model: eCollection Cited Medium: Print ISSN: 2452-073X (Print) Linking ISSN: 2452073X NLM ISO Abbreviation: Neurobiol Pain Subsets: PubMed not MEDLINE